Pacira Pharmaceuticals(PCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PCRX Pacira Pharmaceuticals

盘后交易 04-30 17:47:23 EDT

26.90

-0.10

-0.37%

盘后26.90

+0.000.00%

17:41 EDT

最高27.08	最低26.38	成交量83.83万
今开26.79	昨收27.00	日振幅2.58%
总市值12.45亿	流通市值12.33亿	总股本4,628万
成交额2,249万	换手率1.83%	流通股本4,583万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PCRX","market":"US","secType":"STK","nameCN":"Pacira Pharmaceuticals","latestPrice":26.9,"timestamp":1746043200000,"preClose":27,"halted":0,"volume":838311,"hourTrading":{"tag":"盘后","latestPrice":26.9,"preClose":26.9,"latestTime":"17:41 EDT","volume":34622,"amount":931333.5657220001,"timestamp":1746049274712},"delay":0,"floatShares":45825454,"shares":46276241,"eps":-2.152881,"marketStatus":"盘后交易","change":-0.1,"latestTime":"04-30 17:47:23 EDT","open":26.79,"high":27.0773,"low":26.38,"amount":22485451.769697,"amplitude":0.025826,"askPrice":29.52,"askSize":20,"bidPrice":26.55,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-2.152881,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1746057600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1296709200000,"exchange":"NASDAQ","adjPreClose":27,"preHourTrading":{"tag":"盘前","latestPrice":27.15,"preClose":27,"latestTime":"08:26 EDT","volume":8,"amount":215.730008,"timestamp":1746015994324},"postHourTrading":{"tag":"盘后","latestPrice":26.9,"preClose":26.9,"latestTime":"17:41 EDT","volume":34622,"amount":931333.5657220001,"timestamp":1746049274712},"volumeRatio":1.020935,"impliedVol":0.6374,"impliedVolPercentile":0.456},"requestUrl":"/m/hq/s/PCRX/wiki","defaultTab":"wiki","newsList":[{"id":"2531267350","title":"Pacira Biosciences, Inc.盘中异动 大幅上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531267350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531267350?lang=zh_cn&edition=full","pubTime":"2025-04-29 03:55","pubTimestamp":1745870157,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日03时55分，Pacira Biosciences, Inc.股票出现异动，股价急速上涨5.17%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.27%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504290355579748ece7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504290355579748ece7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UPC","BK4007","PCRX"],"gpt_icon":0},{"id":"2529802188","title":"Pacira Biosciences, Inc.盘中异动 大幅上涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529802188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529802188?lang=zh_cn&edition=full","pubTime":"2025-04-21 21:31","pubTimestamp":1745242293,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时31分，Pacira Biosciences, Inc.股票出现波动，股价快速拉升5.42%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.10%。其相关个股中，Sunshine Biopharma Inc.、Cardiol Therapeutics Inc.、Medicus Pharma Ltd.涨幅较大，Sunshine Biopharma Inc.、Redhill Biopharma Ltd、苏轩堂较为活跃，换手率分别为147.12%、3.01%、1.58%，振幅较大的相关个股有Sunshine Biopharma Inc.、大自然药业、Alpha Teknova, Inc.，振幅分别为8.00%、6.74%、6.25%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421213133aa2c73b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421213133aa2c73b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2518447094","title":"Pacira Biosciences, Inc.2024财年实现净利润-99.56百万美元，同比减少337.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518447094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518447094?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:00","pubTimestamp":1741449618,"startTime":"0","endTime":"0","summary":"3月9日，Pacira Biosciences, Inc.公布财报，公告显示公司2024财年净利润为-99.56百万美元，同比减少337.27%；其中营业收入为7.01亿美元，同比增加3.85%，每股基本收益为-2.15美元。从资产负债表来看，Pacira Biosciences, Inc.总负债7.75亿美元，其中短期债务2.11亿美元，资产负债比为2.01，流动比率为2.41。机构评级：截至2025年3月9日，当前有7家机构对Pacira Biosciences, Inc.目标价做出预测，其中目标均价为30.86美元，其中最低目标价为21.00美元，最高目标价为48.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000024abef96df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000024abef96df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX"],"gpt_icon":0},{"id":"2516663179","title":"Pacira Biosciences, Inc.盘中异动 股价大跌5.11%报22.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516663179?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:44","pubTimestamp":1741034657,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时44分，Pacira Biosciences, Inc.股票出现异动，股价急速下挫5.11%。截至发稿，该股报22.82美元/股，成交量68.1483万股，换手率1.47%，振幅5.30%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.77%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044417989a6239&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044417989a6239&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2516583648","title":"巴克莱：维持Pacira BioSciences(PCRX.US)评级，由增持调整至增持评级, 目标价由17.00美元调整至24.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516583648","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516583648?lang=zh_cn&edition=full","pubTime":"2025-03-01 07:12","pubTimestamp":1740784345,"startTime":"0","endTime":"0","summary":"巴克莱：维持Pacira BioSciences(PCRX.US)评级，由增持调整至增持评级, 目标价由17.00美元调整至24.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01071248470461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PCRX"],"gpt_icon":0},{"id":"2516777379","title":"Pacira Biosciences, Inc.盘中异动 早盘大幅跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516777379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516777379?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:11","pubTimestamp":1740759087,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时11分，Pacira Biosciences, Inc.股票出现异动，股价急速下跌5.02%。Pacira Biosciences, Inc.股票所在的制药行业中，整体跌幅为0.17%。其相关个股中，Organogenesis Holdings Inc.、百利高、Sunshine Biopharma Inc C/Wts 涨幅较大，Organogenesis Holdings Inc.、苏轩堂、Petros Pharmaceuticals, Inc.较为活跃，换手率分别为31.48%、11.69%、8.11%，振幅较大的相关个股有Organogenesis Holdings Inc.、Sunshine Biopharma Inc C/Wts 、苏轩堂，振幅分别为57.65%、44.90%、18.00%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301001127a2581ab5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301001127a2581ab5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX","BK4007"],"gpt_icon":0},{"id":"2514353594","title":"Pacira BioSciences(PCRX.US)：2024年Q4财报实现营收1.873亿美元，前值为1.812亿美元，预期值为1.854亿美元；每股收益为0.91美元，前值为0.89美元，预期值为0.83美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514353594","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514353594?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:21","pubTimestamp":1740691300,"startTime":"0","endTime":"0","summary":"Pacira BioSciences(PCRX.US)：2024年Q4财报实现营收1.873亿美元，前值为1.812亿美元，预期值为1.854亿美元；每股收益为0.91美元，前值为0.89美元，预期值为0.83美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28052148442333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PCRX"],"gpt_icon":0},{"id":"1111707273","title":"Pacira BioSciences 第四季度调整后每股收益 $0.91 超预期 $0.84，销售额 $1.8725 亿超预期 $1.8436 亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1111707273","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111707273?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:18","pubTimestamp":1740691121,"startTime":"0","endTime":"0","summary":"Pacira BioSciences公布季度每股收益为 $0.91，较分析师一致预期的 $0.84 高出 8.33%。公司报告季度销售额为 $1.8725 亿，较分析师一致预期的 $1.8436 亿高出 1.57%。相比去年同期的 $1.8124 亿，销售额增长了 3.32%。以上内容来自Benzinga Earnings专栏，原文如下：Pacira BioSciences  reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.84 by 8.33 percent. This is a 2.25 percent increase over earnings of $0.89 per share from the same period last year.  The company reported quarterly sales of $187.25 million which beat the analyst consensus estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Pacira BioSciences 第四季度调整后每股收益 $0.91 超预期 $0.84，销售额 $1.8725 亿超预期 $1.8436 亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCRX"],"gpt_icon":0},{"id":"2514072851","title":"Pacira Biosciences, Inc.盘中异动 早盘快速拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514072851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514072851?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:12","pubTimestamp":1740582737,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时12分，Pacira Biosciences, Inc.股票出现波动，股价快速拉升5.14%。Pacira Biosciences, Inc.股票所在的制药行业中，整体跌幅为0.22%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Sunshine Biopharma Inc C/Wts 、Lantheus Holdings, Inc.涨幅较大，Petros Pharmaceuticals, Inc.、苏轩堂、大自然药业较为活跃，换手率分别为18.72%、18.39%、7.60%，振幅较大的相关个股有Sunshine Biopharma Inc C/Wts 、Lantheus Holdings, Inc.、Alvotech C/Wts ，振幅分别为39.06%、18.48%、17.83%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022623121796315784&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022623121796315784&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2507735086","title":"Pacira Biosciences, Inc.盘中异动 急速上涨5.38%报27.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507735086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507735086?lang=zh_cn&edition=full","pubTime":"2025-01-31 00:41","pubTimestamp":1738255280,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日00时41分，Pacira Biosciences, Inc.股票出现异动，股价快速拉升5.38%。截至发稿，该股报27.43美元/股，成交量39.5124万股，换手率0.86%，振幅6.38%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.88%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131004120abbd6388&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131004120abbd6388&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX","BK4007"],"gpt_icon":0},{"id":"2507620584","title":"Truist Securities：上调Pacira BioSciences(PCRX.US)评级，由卖出调整至持有评级, 目标价由8.00美元调整至25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507620584","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507620584?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:51","pubTimestamp":1738252273,"startTime":"0","endTime":"0","summary":"Truist Securities：上调Pacira BioSciences(PCRX.US)评级，由卖出调整至持有评级, 目标价由8.00美元调整至25.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/30235147910758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PCRX"],"gpt_icon":0},{"id":"2505786464","title":"Pacira Biosciences, Inc.盘中异动 早盘股价大涨5.36%报24.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505786464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505786464?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:12","pubTimestamp":1737731574,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时12分，Pacira Biosciences, Inc.股票出现波动，股价快速拉升5.36%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为1.00%。其相关个股中，诺和诺德、Sonoma Pharmaceuticals, Inc.、Painreform Ltd.涨幅较大，Painreform Ltd.、Inmed Pharmaceuticals Inc.、Cbdmd, Inc.较为活跃，换手率分别为205.67%、12.48%、7.00%，振幅较大的相关个股有Painreform Ltd.、博美集团、阿玛琳，振幅分别为17.24%、9.36%、8.96%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124231254abb757a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124231254abb757a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX","BK4007"],"gpt_icon":0},{"id":"2503506560","title":"加拿大皇家银行：重申Pacira BioSciences(PCRX.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由18.00美元调整至18.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503506560","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503506560?lang=zh_cn&edition=full","pubTime":"2025-01-15 00:53","pubTimestamp":1736873635,"startTime":"0","endTime":"0","summary":"加拿大皇家银行：重申Pacira BioSciences(PCRX.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由18.00美元调整至18.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/15005347459088.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PCRX"],"gpt_icon":0},{"id":"2503110536","title":"Pacira Biosciences, Inc.盘中异动 快速上涨5.28%报21.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503110536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503110536?lang=zh_cn&edition=full","pubTime":"2025-01-14 01:56","pubTimestamp":1736791007,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日01时56分，Pacira Biosciences, Inc.股票出现异动，股价大幅拉升5.28%。截至发稿，该股报21.73美元/股，成交量41.1842万股，换手率0.89%，振幅7.67%。Pacira Biosciences, Inc.股票所在的制药行业中，整体跌幅为0.69%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140156479864f6d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140156479864f6d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX","BK4007"],"gpt_icon":0},{"id":"2503307350","title":"Needham：维持Pacira BioSciences(PCRX.US)评级，由买入调整至买入评级, 目标价由22.00美元调整至30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503307350","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503307350?lang=zh_cn&edition=full","pubTime":"2025-01-13 21:50","pubTimestamp":1736776256,"startTime":"0","endTime":"0","summary":"Needham：维持Pacira BioSciences(PCRX.US)评级，由买入调整至买入评级, 目标价由22.00美元调整至30.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/13215047401864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PCRX"],"gpt_icon":0},{"id":"2502862614","title":"Pacira Biosciences, Inc.盘中异动 早盘股价大涨7.64%报20.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502862614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502862614?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:32","pubTimestamp":1736519555,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时32分，Pacira Biosciences, Inc.股票出现波动，股价大幅拉升7.64%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.10%。其相关个股中，Intra-Cellular Therapies Inc.、Pacira Biosciences, Inc.、Kamada Ltd.涨幅较大，大自然药业、Biofrontera Inc.、Tilray Brands, Inc.较为活跃，换手率分别为14.20%、1.80%、1.25%，振幅较大的相关个股有大自然药业、Intra-Cellular Therapies Inc.、Tilray Brands, Inc.，振幅分别为7.10%、7.08%、6.57%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223235aba602e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223235aba602e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2491376644","title":"Pacira Biosciences, Inc.盘中异动 快速下跌5.33%报18.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491376644","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491376644?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:53","pubTimestamp":1734101634,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时53分，Pacira Biosciences, Inc.股票出现异动，股价大幅跳水5.33%。截至发稿，该股报18.75美元/股，成交量2.8236万股，换手率0.06%，振幅5.76%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.15%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213225354a1ec3d18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213225354a1ec3d18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX","BK4007"],"gpt_icon":0},{"id":"2488435118","title":"Pacira Biosciences, Inc.盘中异动 早盘股价大涨5.01%报17.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488435118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488435118?lang=zh_cn&edition=full","pubTime":"2024-12-04 23:25","pubTimestamp":1733325924,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日23时25分，Pacira Biosciences, Inc.股票出现异动，股价快速上涨5.01%。截至发稿，该股报17.52美元/股，成交量8.8811万股，换手率0.19%，振幅5.22%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.57%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120423252498e55f9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120423252498e55f9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX","BK4007"],"gpt_icon":0},{"id":"2488498340","title":"Pacira Biosciences, Inc.盘中异动 临近收盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488498340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488498340?lang=zh_cn&edition=full","pubTime":"2024-12-03 04:43","pubTimestamp":1733172194,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日04时43分，Pacira Biosciences, Inc.股票出现异动，股价大幅拉升5.00%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.50%。其相关个股中，Gelteq Limited、博美集团、Painreform Ltd.涨幅较大，Painreform Ltd.、大自然药业、Sunshine Biopharma Inc.较为活跃，换手率分别为95.87%、29.30%、23.21%，振幅较大的相关个股有Biofrontera Inc C/Wts 27/10/2026 、Gelteq Limited、大自然药业，振幅分别为68.31%、56.50%、52.25%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203044314a26742c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203044314a26742c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2486900758","title":"Pacira Biosciences, Inc.盘中异动 早盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486900758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486900758?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:13","pubTimestamp":1732633993,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时13分，Pacira Biosciences, Inc.股票出现异动，股价急速下挫5.07%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为1.23%。其相关个股中，Biofrontera Inc C/Wts 27/10/2026 、Sunshine Biopharma Inc.、Aytu Biopharma, Inc.涨幅较大，Painreform Ltd.、Sunshine Biopharma Inc.、Sonoma Pharmaceuticals, Inc.较为活跃，换手率分别为17.39%、13.15%、5.49%，振幅较大的相关个股有Quantum Biopharma Ltd.、Sunshine Biopharma Inc.、Scilex Holding Company，振幅分别为15.71%、15.16%、14.12%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112623131398e44b24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112623131398e44b24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pacira.com","stockEarnings":[{"period":"1week","weight":0.0609},{"period":"1month","weight":0.0839},{"period":"3month","weight":0.0373},{"period":"6month","weight":0.6265},{"period":"1year","weight":0.0365},{"period":"ytd","weight":0.4331}],"compareEarnings":[{"period":"1week","weight":0.0513},{"period":"1month","weight":-0.0024},{"period":"3month","weight":-0.0789},{"period":"6month","weight":-0.0252},{"period":"1year","weight":0.0868},{"period":"ytd","weight":-0.0542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Pacira BioSciences, Inc.成立于2006年12月，自2007年3月以来一直在开展与EXPAREL相关的业务。该公司是一家专注于开发、商业化和制造医药产品的专业制药公司，基于公司专有的DepoFoam给药技术，主要用于医院和门诊手术中心。该公司经营一个可报告的分部。2011年10月28日，美国食品药品监督管理局（FDA）批准了公司的新药申请，即NDA，用于公司的主要候选产品EXPAREL，一种布比卡因的脂质体注射液，一种适用于浸润到手术部位以产生术后镇痛长达72小时的酰胺型局部麻醉剂。该公司认为，EXPAREL解决了对长效非阿片类术后镇痛剂的重大未满足的医疗需求，从而简化了术后疼痛管理并减少了阿片类药物的消耗，从而改善了患者的治疗效果并提高了医院经济效益。公司发展了一支完全致力于将EXPAREL商业化的内部销售队伍，公司于2012年4月将其商业化推出。此外，继试点计划后，自2013年10月1日起，公司任命CrossLink BioScience，LLC或CrossLink作为独家第三方分销商，为期五年，在美国推广和销售用于骨科和脊柱手术的EXPAREL，但某些地理区域和账户除外，可能会根据双方协议进行变更和调整。","yearOnYearQuotes":[{"month":1,"riseRate":0.642857,"avgChangeRate":0.06786},{"month":2,"riseRate":0.642857,"avgChangeRate":0.021525},{"month":3,"riseRate":0.466667,"avgChangeRate":-0.005065},{"month":4,"riseRate":0.6,"avgChangeRate":0.040366},{"month":5,"riseRate":0.571429,"avgChangeRate":0.025955},{"month":6,"riseRate":0.428571,"avgChangeRate":0.019619},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.025732},{"month":8,"riseRate":0.5,"avgChangeRate":-0.000921},{"month":9,"riseRate":0.357143,"avgChangeRate":-0.009931},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.017543},{"month":11,"riseRate":0.714286,"avgChangeRate":0.063401},{"month":12,"riseRate":0.571429,"avgChangeRate":0.038038}],"exchange":"NASDAQ","name":"Pacira Pharmaceuticals","nameEN":"Pacira Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pacira Pharmaceuticals(PCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Pacira Pharmaceuticals(PCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Pacira Pharmaceuticals,PCRX,Pacira Pharmaceuticals股票,Pacira Pharmaceuticals股票老虎,Pacira Pharmaceuticals股票老虎国际,Pacira Pharmaceuticals行情,Pacira Pharmaceuticals股票行情,Pacira Pharmaceuticals股价,Pacira Pharmaceuticals股市,Pacira Pharmaceuticals股票价格,Pacira Pharmaceuticals股票交易,Pacira Pharmaceuticals股票购买,Pacira Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pacira Pharmaceuticals(PCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Pacira Pharmaceuticals(PCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}